USPTO serial 87643472
WAFE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- LOOK, JEFFREY J
- Law office
- TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with WAFE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Burlington, Ontario, CA
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical Slurry used in the manufacture of pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments and solutions; Constituents, namely, chemicals, plant extracts, film-forming polymers, plasticizers, and flavoring agents used in the manufacture of pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments, and solutions | INACTIVE - INSUFFICIENT FEE RECEIVED | — |
| 003 | Constituents, namely, chemicals, plant extracts, film-forming polymers, plasticizers, and flavoring agents used in the manufacture of pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments, and solutions | INACTIVE - INSUFFICIENT FEE RECEIVED | — |
| 005 | Delivery platforms, namely, edible wafers and edible films | ACTIVE | — |
| 007 | Equipment for the manufacture of pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments, solutions, namely, production line equipment | INACTIVE - INSUFFICIENT FEE RECEIVED | — |
| 009 | Equipment for the manufacture of pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments, solutions, namely, production line equipment; Equipment for the development of pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments, solutions, namely, production line equipment; Equipment for research in the area of pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments, solutions, namely, production line equipment; Laboratory equipment related to pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments, solutions, namely, production line equipment | INACTIVE - INSUFFICIENT FEE RECEIVED | — |
| 029 | Caffeine based products, namely, caffeine-containing edible wafers and edible films | INACTIVE - INSUFFICIENT FEE RECEIVED | — |
| 032 | Physical energy enhancing products, namely, natural chemical drinks | INACTIVE - INSUFFICIENT FEE RECEIVED | — |
| 040 | Turnkey operations in the field of the manufacturing to the order and specification of others of pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments and solutions | INACTIVE - INSUFFICIENT FEE RECEIVED | — |
| 042 | Consulting in the field of scientific and medical research and new product development related to pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments and solutions | INACTIVE - INSUFFICIENT FEE RECEIVED | — |
| 044 | Consulting in the field of the medical and health risks, and benefits related to pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments and solutions | INACTIVE - INSUFFICIENT FEE RECEIVED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Rapid Dose Therapeutics Inc.
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 029
- Other trademarks in Class 032
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named WAFE
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 19, 2019 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 16, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 19, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 17, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 17, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 17, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 28, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 28, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 28, 2018 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 28, 2018 | ALIE | ASSIGNED TO LIE | — |
| Nov 18, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 18, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 18, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 18, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 18, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 8, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 2, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 20, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |